| Dr Jaspreet K Prischmann, MD | |
|
701 Xenia Ave S Ste 450, Minneapolis, MN 55416-1082 | |
| (952) 567-7151 | |
| (952) 567-7154 |
| Full Name | Dr Jaspreet K Prischmann |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology |
| Experience | 19 Years |
| Location | 701 Xenia Ave S Ste 450, Minneapolis, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710996921 | NPI | - | NPPES |
| P00632050 | Other | MN | RAILROAD MEDICARE |
| 966487000 | Medicaid | MN |
| Entity Name | Prischmann Facial Plastic Surgery, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730450297 PECOS PAC ID: 6709045727 Enrollment ID: O20120312000497 |
News Archive
Cases of gonorrhea and syphilis are increasing in Australia, according to the most recent Annual Surveillance Report on HIV, viral hepatitis and sexually transmissible infections (STIs) in Australia.
As physicians and health policy experts debate the merits of Aduhelm, the first new drug for Alzheimer's disease approved in 18 years, patients want to know: "Will this medication help me — and how much?"
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has been granted a pre-Investigational New Drug meeting with the U.S. Food and Drug Administration on November 22nd, 2011 to discuss the initial clinical development plan for ADXS-HER2, a construct for the treatment of HER2 expressing cancers.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, announced today that the target enrollment has been reached for the Phase 2 study of belinostat in Carcinoma of Unknown Primary (CUP).
In women who have experienced trauma, post-traumatic stress disorder symptoms may vary over the course of the menstrual cycle, with more symptoms during the first few days of the cycle when the hormone estradiol is low, and fewer symptoms close to ovulation, when estradiol is high, finds research published by the American Psychological Association.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jaspreet K Prischmann, MD 701 Xenia Ave S Ste 450, Minneapolis, MN 55416-1082 Ph: (952) 567-7151 | Dr Jaspreet K Prischmann, MD 701 Xenia Ave S Ste 450, Minneapolis, MN 55416-1082 Ph: (952) 567-7151 |
News Archive
Cases of gonorrhea and syphilis are increasing in Australia, according to the most recent Annual Surveillance Report on HIV, viral hepatitis and sexually transmissible infections (STIs) in Australia.
As physicians and health policy experts debate the merits of Aduhelm, the first new drug for Alzheimer's disease approved in 18 years, patients want to know: "Will this medication help me — and how much?"
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has been granted a pre-Investigational New Drug meeting with the U.S. Food and Drug Administration on November 22nd, 2011 to discuss the initial clinical development plan for ADXS-HER2, a construct for the treatment of HER2 expressing cancers.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, announced today that the target enrollment has been reached for the Phase 2 study of belinostat in Carcinoma of Unknown Primary (CUP).
In women who have experienced trauma, post-traumatic stress disorder symptoms may vary over the course of the menstrual cycle, with more symptoms during the first few days of the cycle when the hormone estradiol is low, and fewer symptoms close to ovulation, when estradiol is high, finds research published by the American Psychological Association.
› Verified 6 days ago
Jeffrey C. Manlove, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2211 Park Ave, Minneapolis, MN 55404 Phone: 612-871-1144 Fax: 612-871-2012 | |
Richard M. Levinson, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2211 Park Ave, Minneapolis, MN 55404 Phone: 612-871-1144 Fax: 612-871-2012 | |
Robert H Maisel, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 701 Park Ave, P7, Minneapolis, MN 55415 Phone: 612-873-2424 | |
Sivakumar Chinnadurai, MD, MPH Otolaryngology Medicare: Medicare Enrolled Practice Location: 2530 Chicago Ave Ste 450, Minneapolis, MN 55404 Phone: 615-813-6000 | |
Samir Suresh Khariwala, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 516 Delaware St Se, Clinic 8a, Minneapolis, MN 55455 Phone: 612-625-7400 | |
Tina Chung-ting Huang, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 420 Delaware St Se, University Of Minnesota Physicians, Minneapolis, MN 55455 Phone: 612-626-5900 | |
Carrie E Flanagan, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 420 Delaware St Se, Mmc 293, Minneapolis, MN 55455 Phone: 612-625-7634 |